公开(公告)号：US20080104422A1

公开(公告)日：2008-05-01

申请号：US11554247

申请日：2006-10-30

Applicant: Samuel L. Mullis ,  Mark Steven Frisbee

Inventor： Samuel L. Mullis ,  Mark Steven Frisbee

IPC: G06F1/00

CPC classification number: G06F1/266 ,  G06F1/3215 ,  G06F1/3253 ,  Y02D10/151

Abstract: A USB bus-powered device in Suspend state that requires active bus state power levels, but has no data transfer need, may initiate Resume signaling to return a USB bus segment to active state, without transferring any data across the bus. A device driver considers both USB device power needs and data transfer activity in deciding to Globally or Selectively Suspend a bus or bus segment. In particular, upon deciding to Suspend a bonus or bus segment, the device driver queries a USB bus-powered device. If the device will require active bus mode power within a predetermined duration, the device will indicate to the device driver to remain an active mode. In this case, the device driver does not direct the USB host to Suspend the bus.

Abstract translation: 一个处于暂停状态的USB总线供电器件，需要有效的总线状态功率电平，但没有数据传输需要，可能会启动恢复信号使USB总线段恢复到活动状态，而不会通过总线传输任何数据。 设备驱动程序考虑USB设备电源需求和数据传输活动来决定全局或选择性暂停总线或总线段。 特别是，在决定暂停红利或总线段时，设备驱动程序查询USB总线供电的设备。 如果设备将在预定持续时间内要求有源总线模式电源，则设备将向设备驱动器指示保持活动模式。 在这种情况下，设备驱动程序不会指示USB主机挂起总线。

公开(公告)号：US08323692B2

公开(公告)日：2012-12-04

申请号：US12328828

申请日：2008-12-05

Applicant: Steven Frisbee

Inventor： Steven Frisbee

IPC: A61K9/16 ,  A61K9/20 ,  A61K9/28 ,  A61K9/38

CPC classification number: A61K9/2893 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/2846 ,  A61K9/2853 ,  A61K9/2866 ,  A61K31/135

Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.

Abstract translation: 本发明提供用于涂覆药物口服剂型的稳定的控释单片涂料组合物，其包含熔点大于55℃的聚二醇和缺乏官能团的中性酯共聚物的水分散体。

公开(公告)号：US20100141609A1

公开(公告)日：2010-06-10

申请号：US12330795

申请日：2008-12-09

Applicant: Mark Steven Frisbee

Inventor： Mark Steven Frisbee

IPC: G06F3/033

CPC classification number: G06F3/0362 ,  G06F3/0234 ,  G06F3/0236 ,  G06F3/0338

Abstract: An electronic device includes a housing that encloses a controller and/or other electronic components, a display viewable through a face of the housing that is configured to display an alphanumeric character list, and an input device adjacent the display that is movable by a user to highlight and select respective alphanumeric characters in a displayed character list. To highlight characters within a displayed character list, the input device is rotatable about an axis that is substantially normal to the display and is slidable within a plane that is substantially orthogonal to the axis. In some embodiments, the input device is rotatable and slidable within a plane that is substantially parallel with a plane defined by the housing face. To select a highlighted character, a user depresses the input device.

Abstract translation: 一种电子设备包括：壳体，其包围控制器和/或其它电子部件;可通过外壳的面部可以显示字母数字字符列表的显示器;以及与用户可移动的显示器相邻的输入设备 在显示的字符列表中突出显示并选择相应的字母数字字符。 为了突出显示的字符列表中的字符，输入设备可以围绕基本上垂直于显示器的轴线旋转，并且可在基本上垂直于轴线的平面内滑动。 在一些实施例中，输入装置可在与由壳体面限定的平面基本平行的平面内旋转和滑动。 要选择突出显示的字符，用户按下输入设备。

公开(公告)号：US20090258067A1

公开(公告)日：2009-10-15

申请号：US12425819

申请日：2009-04-17

Applicant: Fang ZHOU ,  Paul Maes ,  Steven Frisbee

Inventor： Fang ZHOU ,  Paul Maes ,  Steven Frisbee

IPC: A61K9/24 ,  A61K31/137

CPC classification number: A61K9/2018 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/284 ,  A61K9/2866

Abstract: The present invention relates to a modified release composition of at least one form of venlafaxine, which is an enhanced absorption delayed controlled release composition. The composition comprises a core comprising at least one form of venlafaxine, less than 10% of a gelling agent and a pharmaceutically acceptable excipient. The composition further comprises a modified release coating which substantially surrounds the core which provides a delayed controlled release of the at least one form of venlafaxine.

Abstract translation: 本发明涉及至少一种形式的文拉法辛的改进释放组合物，其是增强的吸收延迟控释组合物。 组合物包含包含至少一种形式的文拉法辛，小于10％的胶凝剂和药学上可接受的赋形剂的核心。 所述组合物还包含基本上围绕所述芯的改性释放涂层，其提供所述至少一种形式的文拉法辛的延迟控制释放。

公开(公告)号：US08982105B2

公开(公告)日：2015-03-17

申请号：US12330795

申请日：2008-12-09

Applicant: Mark Steven Frisbee

Inventor： Mark Steven Frisbee

IPC: G06F3/033 ,  G06F3/0362 ,  G06F3/023 ,  G06F3/0338

CPC classification number: G06F3/0362 ,  G06F3/0234 ,  G06F3/0236 ,  G06F3/0338

Abstract: An electronic device includes a housing that encloses a controller and/or other electronic components, a display viewable through a face of the housing that is configured to display an alphanumeric character list, and an input device adjacent the display that is movable by a user to highlight and select respective alphanumeric characters in a displayed character list. To highlight characters within a displayed character list, the input device is rotatable about an axis that is substantially normal to the display and is slidable within a plane that is substantially orthogonal to the axis. In some embodiments, the input device is rotatable and slidable within a plane that is substantially parallel with a plane defined by the housing face. To select a highlighted character, a user depresses the input device.

Abstract translation: 一种电子设备包括：壳体，其包围控制器和/或其它电子部件;可通过外壳的面部可以显示字母数字字符列表的显示器;以及与用户可移动的显示器相邻的输入设备 在显示的字符列表中突出显示并选择相应的字母数字字符。 为了突出显示的字符列表中的字符，输入设备可以围绕基本上垂直于显示器的轴线旋转，并且可在基本上垂直于轴线的平面内滑动。 在一些实施例中，输入装置可在与由壳体面限定的平面基本平行的平面内旋转和滑动。 要选择突出显示的字符，用户按下输入设备。

公开(公告)号：US20120231080A1

公开(公告)日：2012-09-13

申请号：US13475118

申请日：2012-05-18

Applicant: Steven FRISBEE

Inventor： Steven FRISBEE

IPC: A61K9/14 ,  A61K31/155

CPC classification number: A61K9/2893 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/2846 ,  A61K9/2853 ,  A61K9/2866 ,  A61K31/135

Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.

Abstract translation: 本发明提供用于涂覆药物口服剂型的稳定的控释单片涂料组合物，其包含熔点大于55℃的聚二醇和缺乏官能团的中性酯共聚物的水分散体。

公开(公告)号：US07873841B2

公开(公告)日：2011-01-18

申请号：US11554247

申请日：2006-10-30

Applicant: Samuel L. Mullis, II ,  Mark Steven Frisbee

Inventor： Samuel L. Mullis, II ,  Mark Steven Frisbee

IPC: G06F1/26

CPC classification number: G06F1/266 ,  G06F1/3215 ,  G06F1/3253 ,  Y02D10/151

Abstract: A USB bus-powered device in Suspend state that requires active bus state power levels, but has no data transfer need, may initiate Resume signaling to return a USB bus segment to active state, without transferring any data across the bus. A device driver considers both USB device power needs and data transfer activity in deciding to Globally or Selectively Suspend a bus or bus segment. In particular, upon deciding to Suspend a bonus or bus segment, the device driver queries a USB bus-powered device. If the device will require active bus mode power within a predetermined duration, the device will indicate to the device driver to remain an active mode. In this case, the device driver does not direct the USB host to Suspend the bus.

Abstract translation: 一个处于暂停状态的USB总线供电器件，需要有效的总线状态功率电平，但没有数据传输需要，可能会启动恢复信号使USB总线段恢复到活动状态，而不会通过总线传输任何数据。 设备驱动程序考虑USB设备电源需求和数据传输活动来决定全局或选择性暂停总线或总线段。 特别是，在决定暂停红利或总线段时，设备驱动程序查询USB总线供电的设备。 如果设备将在预定持续时间内要求有源总线模式电源，则设备将向设备驱动器指示保持活动模式。 在这种情况下，设备驱动程序不会指示USB主机挂起总线。

公开(公告)号：US20080175873A1

公开(公告)日：2008-07-24

申请号：US11947883

申请日：2007-11-30

Applicant: Fang Zhou ,  Paul Maes ,  Steven Frisbee

Inventor： Fang Zhou ,  Paul Maes ,  Steven Frisbee

IPC: A61K9/00 ,  A61K31/137 ,  A61P25/24

CPC classification number: A61K9/2018 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/284 ,  A61K9/2866

Abstract: The present invention relates to a modified release composition of at least one form of venlafaxine, which is an enhanced absorption delayed controlled release composition. The composition comprises a core comprising at least one form of venlafaxine, less than 10% of a gelling agent and a pharmaceutically acceptable excipient. The composition further comprises a modified release coating which substantially surrounds the core which provides a delayed controlled release of the at least one form of venlafaxine.

Abstract translation: 本发明涉及至少一种形式的文拉法辛的改进释放组合物，其是增强的吸收延迟控释组合物。 组合物包含包含至少一种形式的文拉法辛，小于10％的胶凝剂和药学上可接受的赋形剂的核心。 所述组合物还包含基本上围绕所述芯的改性释放涂层，其提供所述至少一种形式的文拉法辛的延迟控制释放。

公开(公告)号：US08110219B2

公开(公告)日：2012-02-07

申请号：US12328828

申请日：2008-12-05

Applicant: Steven Frisbee

Inventor： Steven Frisbee

IPC: A61K9/16 ,  A61K9/20 ,  A61K9/28 ,  A61K9/38

Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.

公开(公告)号：US20120231081A1

公开(公告)日：2012-09-13

申请号：US13475354

申请日：2012-05-18

Applicant: Steven FRISBEE

Inventor： Steven FRISBEE

IPC: A61K31/155 ,  A61K9/14

CPC classification number: A61K9/2893 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/2846 ,  A61K9/2853 ,  A61K9/2866 ,  A61K31/135

Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.